BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 2524143)

  • 21. Increased migration inhibition factor production by leukocytes of patients with herpes zoster given the leukocyte ultrafiltrate.
    Lackovicová M; Zachar V; Necas S; Mayer V
    Acta Virol; 1989 Sep; 33(5):428-34. PubMed ID: 2576583
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The Rebuck skin window method in the differentiated assessment of the activity of phagocytic reactions in patients with foot mycoses and eczema].
    Iutskovskiĭ AD
    Vestn Dermatol Venerol; 1988; (6):16-9. PubMed ID: 3051772
    [No Abstract]   [Full Text] [Related]  

  • 23. [Leukocyte migration inhibition reaction in evaluating increased sensitivity of the delayed type in fungal infection].
    Fedotov VP; Matvienko DA
    Vestn Dermatol Venerol; 1978 Oct; (10):15-9. PubMed ID: 706728
    [No Abstract]   [Full Text] [Related]  

  • 24. [Modified leukocyte migration inhibition test with workers of the buildings and metals industries with chromium eczema].
    Bowszyc J; Bowszyc J; Hryniewiecka I
    Med Pr; 1981; 32(6):423-7. PubMed ID: 6210822
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Body reactivity in foot mycoses].
    Kilikeev AA
    Voen Med Zh; 1979 Oct; (10):63. PubMed ID: 506105
    [No Abstract]   [Full Text] [Related]  

  • 26. [State of allergic reactivity to dermatophyes, pyococci and yeastlike fungi in patients with mycoses of the feet and eczema].
    Khodiukov EIa
    Vestn Dermatol Venerol; 1973 Feb; 47(2):31-5. PubMed ID: 4585659
    [No Abstract]   [Full Text] [Related]  

  • 27. Technical study of the leucocyte migration inhibition test in agarose. Application to PPD and to hepatitis B antigen.
    Erard P
    Clin Exp Immunol; 1974 Nov; 18(3):439-48. PubMed ID: 4619978
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antigen-specific activity of murine leukocyte dialysates containing transfer factor on human leukocytes in the leukocyte migration inhibition (LMI) assay.
    Borkowsky W; Suleski P; Bhardwaj N; Lawrence HS
    J Immunol; 1981 Jan; 126(1):80-2. PubMed ID: 6161170
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Leucocyte migration inhibition and rosette tests in pleural effusion.
    Jakubusek-Przylipiak M; Janicka G; Zagorecka A; Pregowski W
    Eur J Respir Dis; 1980 Apr; 61(2):67-70. PubMed ID: 6969182
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An immunosuppressive serum factor in widespread cutaneous dermatophytosis.
    Sherwin WK; Ross TH; Rosenthal CM; Petrozzi JW
    Arch Dermatol; 1979 May; 115(5):600-4. PubMed ID: 312623
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Leucocyte migration inhibitory factor assay in Nigerians with urinary schistosomiasis.
    Arinola OG; Salimonu LS
    West Afr J Med; 1999; 18(2):101-5. PubMed ID: 10504865
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Cell migration inhibition factor in the presence of lung extract in patients with productive pulmonary tuberculosis].
    Bernal-Madrazo MA; Celis-Barragán ME; Olivares-Lugo A; Cicero-Sabido R
    Gac Med Mex; 1982 Jun; 118(6):236-8. PubMed ID: 6751919
    [No Abstract]   [Full Text] [Related]  

  • 33. [Studies on the pathogenic mechanism of hypersensitivity to antibacterial agents--correlations of leucocyte migration activating factor and leucocyte migration inhibitory factor with interleukin-2 and interferon-gamma].
    Uno K
    Arerugi; 1993 May; 42(5):656-64. PubMed ID: 8323465
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vitro production of leucocyte migration inhibitory factor by lymphocytes in exudative pleural effusions.
    Pettersson T; Welin MG; Weber TH
    J Clin Lab Immunol; 1982 Jun; 8(2):107-11. PubMed ID: 7050387
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Effect of the serum of patients with an active form of pulmonary sarcoidosis on the biological activity of lymphocytes and leukocytes of healthy persons].
    Wolska-Goszka L
    Pol Tyg Lek; 1984 Feb; 39(7):209-13. PubMed ID: 6379620
    [No Abstract]   [Full Text] [Related]  

  • 36. Studies of cellular immunity in Graves' disease.
    Zosin I; Simionescu L; Arcan P; Lungu G
    Endocrinologie; 1983; 21(4):267-72. PubMed ID: 6364320
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effect of ampicillin on the response of human lymphocytes to PHA.
    Wojtulewicz-Kurkus J; Skopińska-Rózewska EU; Norwaczyk M; Podobińska I
    Arch Immunol Ther Exp (Warsz); 1981; 29(3):361-8. PubMed ID: 7294972
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cell-mediated immunity in amoebic liver abscess.
    Gandhi BM; Gupta H; Irshad M; Chawala TC; Tandon BN
    J Trop Med Hyg; 1986 Aug; 89(4):163-6. PubMed ID: 3491219
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Comparative analysis of immune response indices in lung cancer].
    Govallo VI; Dubrovskiĭ AV; Grigor'eva MP; Kosmiadi GA; Efimtseva NN
    Vopr Onkol; 1985; 31(1):39-44. PubMed ID: 3156450
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Quantitative and functional evaluation of immunoregulating cells and natural killers in patients with aplastic anemia].
    Pogorel'skaia EP; Skriabina EG; Aĭtmatova GS; Saidov MZ; Svirezheva MN
    Ter Arkh; 1985; 57(7):71-4. PubMed ID: 3901381
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.